Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$134,932,195
+$50,597,840 QoQ
Shares Held
1,050,056
+49.8% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#182
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Epoch Investment Partners, Inc. holds $994,368,960 across 9 Drug Manufacturers - General names. MRK ranks #3 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,376,588 | $346,404,603 | |
| 2 | LLY |
ELI LILLY & Co
|
119,698 | $143,569,383 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
1,050,056 | $134,932,195 | |
| 4 | JNJ |
Johnson & Johnson
|
524,387 | $133,178,566 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,141,710 | $65,785,328 | |
| 6 | PFE |
Pfizer Inc
|
2,723,573 | $65,583,636 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
485,736 | $61,367,885 | |
| 8 | AZN |
Astrazeneca PLC
|
157,316 | $29,830,259 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $134,932,195 | 1,050,056 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $84,334,355 | 701,092 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $74,782,072 | 710,451 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $58,172,889 | 693,112 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $57,047,287 | 720,658 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $63,536,435 | 707,848 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $67,852,919 | 682,076 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $95,516,449 | 841,110 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $166,399,207 | 1,344,097 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $160,567,710 | 1,216,883 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $132,598,952 | 1,216,281 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $140,361,821 | 1,363,398 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $159,315,740 | 1,380,672 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $148,906,952 | 1,399,633 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $153,064,954 | 1,379,585 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $165,010,397 | 1,916,052 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $187,011,276 | 2,051,237 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $247,868,617 | 3,020,946 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $207,291,196 | 2,704,739 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $187,714,010 | 2,499,188 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $183,908,473 | 2,364,774 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $253,428,345 | 3,287,433 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $299,540,994 | 3,661,872 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $408,350,512 | 4,922,849 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $398,522,647 | 5,153,530 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $289,536,794 | 3,763,152 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||